Spectrum of Clinical Manifestations in Patients of Scleroderma and Correlation between Cutaneous and Pulmonary Involvement

In systemic sclerosis (SSc) patients, the emergence of severe systemic complications such as pulmonary arterial hypertension and ILD can manifest regardless of disease duration or subtype. Symptoms might not consistently align with disease advancement. Therefore, a thorough evaluation that incorporates symptoms and specialized diagnostic tests, such as pulmonary function tests, echocardiography (ECHO), and HRCT, is crucial for early identification, timely treatment, and better prognosis. The mRSS serves as a valuable clinical instrument for monitoring scleroderma progression.